NeoGenomics, Inc.

NEO · NASDAQ

NeoGenomics, Inc.NEO · NASDAQ

Regular Market · Oct 30, 08:00 PM

$17.38-$0.55 -3.07%

After Hours $17.38 -$0.00 -0.03%

Oct 30, 08:39 PM

High: —
Low: —
Volume: —

Loading chart…

Ask Alva about NEO

NeoGenomics, Inc.

NEO · Medical - Diagnostics & Research

17.38 USD

-0.55 (-3.07%)

At Close

17.38 USD

-0.00 (-0.03%)

After hours

High
Low
Volume
Open
Prev Close
Turnover
Trailing P/E
Market Cap
Turnover Ratio
Free Float
Post-Market
VWAP
Range (%)
Volume Ratio
52-Wk High
52-Wk Low
Forward P/E
Beta

NeoGenomics, Inc.

NEO · NASDAQ

At Close

17.38 USD

-0.55 (-3.07%)

After hours 17.38 USD -0.00 (-0.03%)

High
Low
Volume
Open
Prev Close
Turnover
Trailing P/E
Market Cap
Turnover Ratio
Free Float
Post-Market
VWAP
Range (%)
Volume Ratio
52-Wk High
52-Wk Low
Forward P/E
Beta

Unusual Price Movement

NEO extended its post-Q3 decline as a sharp Nasdaq-led risk-off session added pressure.

No new catalyst: NEO was down about 3.4% in regular trading after falling about 5.0% pre-market following its October 28 Q3 results, despite raised full-year guidance. The Nasdaq fell sharply and the VIX jumped, while diagnostics peers also declined intraday; the post-results reaction remained the standing company-specific driver.

neogenomics.com

Unusual Price Movement

NEO extended its post-Q3 decline as a sharp Nasdaq-led risk-off session added pressure.

Sources:

NeoGenomics Reports Third Quarter 2026 Results

Ask Alva anything. @ for context, / for skills

Ask Alva about NEO

NEO extended its post-Q3 decline as a sharp Nasdaq-led risk-off session added pressure. ⓘ

NEO extended its post-Q3 decline as a sharp Nasdaq-led risk-off session added pressure. ⓘ

NEO extended its post-Q3 decline as a sharp Nasdaq-led risk-off session added pressure.

NEO extended its post-Q3 decline as a sharp Nasdaq-led risk-off session added pressure.